Status:
COMPLETED
IVUS Study for SV Graft: Y-composite vs Aortocoronary Conduit
Lead Sponsor:
Ho Young Hwang
Conditions:
Coronary Artery Disease
Morphologic Change
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Left internal thoracic artery (LITA) has been acknowledged as the first graft of choice for coronary artery bypass grafting (CABG). However, it is still not conclusive which one is the best second gra...
Detailed Description
The enrolled patient underwent routine sternotomy, and left internal thoracic artery (LITA) and saphenous vein (SV) are harvested. After harvest, the patient is randomized to Y-composite group or aort...
Eligibility Criteria
Inclusion
- A patient who is going to receive coronary artery bypass grafting
- Older than 19 years
- Coronary artery bypass grafting is going to be performed with left internal thoracic artery and saphenous vein graft
Exclusion
- Other concomitant procedures (e.g. valve or aorta surgery) is planned
- Patients with severe comorbidities which limit the life expectancy of them below 1 year (e.g. terminal cancer)
- Patients whose left internal thoracic artery or saphenous vein is not available due to the low quality, severe injury, or absence of the graft
Key Trial Info
Start Date :
July 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 27 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04782492
Start Date
July 8 2021
End Date
September 27 2023
Last Update
April 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea